Current European data collection on emergency department presentations with acute recreational drug toxicity: Gaps and national variations

Clinical Toxicology

Volumn 52, Issue 10, 2014, Pages 1005-1012

  Heyerdahl, Fridtjof ^a   Hovda, Knut Erik ^a   Giraudon, Isabelle ^b   Yates, Christopher ^c   Dines, Alison M ^d   Sedefov, Roumen ^b   Wood, David M ^d,e   Dargan, Paul I ^d,e  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^e KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Designer drugs; Drugs of abuse; Emergency department; Emergency room; Epidemiology; Illegal drugs; Novel psychoactive drugs; NPS; Overdose; Street drugs; Surveillance; Toxicology

Indexed keywords

4' METHYLMETHCATHINONE; AMPHETAMINE; CANNABINOID DERIVATIVE; CANNABIS; CATHINONE; COCAINE; DIAMORPHINE; HYDROXYBUTYRIC ACID; METHAMPHETAMINE; MORPHINE; PIPERAZINE; PIPERAZINE DERIVATIVE; PSYCHOTROPIC AGENT; RECREATIONAL DRUG; STREET DRUG;

ACUTE TOXICITY; ARTICLE; DRUG ABUSE; DRUG MONITORING; EMERGENCY WARD; EUROPE; EUROPEAN; GOOD CLINICAL PRACTICE; HUMAN; INFORMATION PROCESSING; RETROSPECTIVE STUDY; SYSTEMATIC REVIEW (TOPIC); DRUG OVERDOSE; EMERGENCY HEALTH SERVICE; FACTUAL DATABASE; HEALTH SURVEY; PROGRAM DEVELOPMENT; QUESTIONNAIRE; SUBSTANCE-RELATED DISORDERS; TIME; TRENDS;

DATA COLLECTION; DATABASES, FACTUAL; DRUG OVERDOSE; EMERGENCY SERVICE, HOSPITAL; EUROPE; HEALTH SURVEYS; HUMANS; PROGRAM DEVELOPMENT; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TIME FACTORS;

EID: 84919968851     PISSN: 15563650     EISSN: 15569519     Source Type: Journal    
DOI: 10.3109/15563650.2014.976792     Document Type: Article

References (38)

1. EMCDDA. European Drug Report 2014. European Monitoring Centre for Drugs and Drug Addiction. Available from: http://www. emcdda.europa.eu/edr2014, 2014.
2. Gibbons S. 'Legal Highs'-novel and emerging psychoactive drugs: a chemical overview for the toxicologist. Clin Toxicol (Phila) 2012; 50:15-24.
3. Wood DM, Dargan PI. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances. Ther Drug Monit 2012; 34:363-367.
4. Vevelstad M, Oiestad EL, Middelkoop G, Hasvold I, Lilleng P, Delav-eris GJ, et al. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications. Forensic Sci Int 2012; 219:151-157.
5. Handley SA, Flanagan RJ. Drugs and other chemicals involved in fatal poisoning in England and Wales during 2000-2011. Clin Toxicol (Phila) 2014; 52:1-12.
6. Schifano F, Corkery J, Ghodse AH. Suspected and conf rmed fatalities associated with mephedrone (4-methylmethcathinone, " meow meow ") in the United Kingdom. J Clin Psychopharmacol 2012; 32:710-714.
7. EMCDDA. Reports on the risk assessment of substances in the framework of the Council Decision on new psychoactive substances 2014 [cited 2014 30.05.2014]. Available from: http://www.emcdda.europa. eu/publications/searchresults?action = list&type = PUBLICATIONS &SERIES-PUB = w12.
8. Giraudon I, Mena G, Matias J, Vicente J, EMCDDA. Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries. Technical report. Lisbon: European Monitoring Centre for Drugs and Drug Addiction, 2014.
9. Wood DM, Davies S, Greene SL, Button J, Holt DW, Ramsey J, et al. Case series of individuals with analytically conf rmed acute mephedrone toxicity. Clin Toxicol (Phila) 2010; 48:924-927.
10. Wood DM, Dargan PI. Understanding how data triangulation identif es acute toxicity of novel psychoactive drugs. J Med Toxicol 2012; 8:300-303.
11. Wood DM, Heyerdahl F, Yates CB, Dines AM, Giraudon I, Hovda KE, et al. The European Drug Emergencies Network (Euro-DEN). Clin Toxicol (Phila) 2014; 52:239-241.
12. Wood DM, Greene SL, Dargan PI. Five-year trends in self-reported recreational drugs associated with presentation to a UK emergency department with suspected drug-related toxicity. Eur J Emerg Med 2013; 20:263-267.
13. Krul J, Girbes AR, Sanou BT Increase in serious ecstasy-related incidents in the Netherlands. Lancet 2012; 380:1385.
14. Wood DM, Nicolaou M, Dargan PI. Epidemiology of recreational drug toxicity in a nightclub environment. Subst Use Misuse 2009; 44:1495-1502.
15. Wood DM, Panayi P, Davies S, Huggett D, Collignon U, Ramsey J, et al. Analysis of recreational drug samples obtained from patients presenting to a busy inner-city emergency department: a pilot study adding to knowledge on local recreational drug use. Emerg Med J 2011; 28:11-13.
16. Sanjurjo E, Camara M, Nogue S, Negredo M, Garcia S, To-Figueras J, et al. Urgencias por consumo de drogas de abuso: confrontaci ó n entre los datos clínicos y los analíticos. Emergencias 2005; 17:26-31.
17. Wood DM, Greene SL, Dargan PI. Emergency department presentations in determining the effectiveness of drug control in the United Kingdom: mephedrone (4-methylmethcathinone) control appears to be effective using this model. Emerg Med J 2013; 30:70-71.
18. James D, Adams RD, Spears R, Cooper G, Lupton DJ, Thompson JP, Thomas SH; National Poisons Information Service. Clinical characteristics of mephedrone toxicity reported to the U.K. National Poisons Information Service. Emerg Med J 2011; 28:686-689.
19. Regan L, Mitchelson M, Macdonald C. Mephedrone toxicity in a Scottish emergency department. Emerg Med J 2011; 28:1055-1058.
20. Wood DM, Button J, Ashraf T, Walker S, Greene SL, Drake N, et al. What evidence is there that the UK should tackle the potential emerging threat of methamphetamine toxicity rather than established recreational drugs such as MDMA ('ecstasy')? QJM 2008; 101:207-213.
21. Galicia M, Nogue S, Miro O. Liquid ecstasy intoxication: clinical features of 505 consecutive emergency department patients. Emerg Med J 2011; 28:462-466.
22. Knudsen K, Jonsson U, Abrahamsson J. Twenty-three deaths with gamma-hydroxybutyrate overdose in western Sweden between 2000 and 2007. Acta Anaesthesiol Scand 2010; 54:987-992.
23. Wood DM, Warren-Gash C, Ashraf T, Greene SL, Shather Z, Trivedy C, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1, 4-butanediol (1, 4BD). QJM 2008; 101:23-29.
24. Bogstrand ST, Normann PT, Rossow I, Larsen M, Morland J, Ekeberg O. Prevalence of alcohol and other substances of abuse among injured patients in a Norwegian emergency department. Drug Alcohol Depend 2011; 117:132-138.
25. Giovanardi D, Castellana CN, Pisa S, Poppi B, Pinetti D, Bertolini A, et al. Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy. Drug Alcohol Depend 2005; 80: 135-138.
26. Wells C. Deaths related to drug poisoning in England and Wales, 2008. Health Stat Q 2009:48-55.
27. Tuusov J, Vals K, Tonisson M, Riikoja A, Denissov G, Vali M. Fatal poisoning in Estonia 2000-2009. Trends in illegal drug-related deaths. Journal J Forensic Leg Med 2013; 20:51-56.
28. Simonsen KW, Normann PT, Ceder G, Vuori E, Thordardottir S, Thelander G, et al. Fatal poisoning in drug addicts in the Nordic countries in 2007. Forensic Sci Int 2011; 207:170-176.
29. Concheiro M, de Castro A, Quintela O, Lopez-Rivadulla M, Cruz A. Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 832:81-89.
30. Brunt TM, Niesink RJ. The Drug Information and Monitoring System (DIMS) in the Netherlands: implementation, results, and international comparison. Drug Test Anal. 2011; 3:621-634.
31. EMCDDA. 2013 National Spanish Report (2012 data) for the EMCDDA 2013. Available from: http://www.emcdda.europa.eu/attachements.cfm/att-228526-EN-EMCDDA-NR 2013-Spain.pdf. Last accessed 26th October 2014.
32. Corkery JM, Durkin E, Elliott S, Schifano F, Ghodse AH. The recreational tryptamine 5-MeO-DALT (N, N-diallyl-5-methoxytryptamine): a brief review. Prog Neuropsychopharmacol Biol Psychiatry 2012; 39: 259-262.
33. Shah AD, Wood DM, Dargan PI. Survey of ICD-10 coding of hospital admissions in the UK due to recreational drug toxicity. QJM 2011;104:779-784.
34. Wood DM, Conran P, Dargan PI. ICD-10 coding: poor identif cation of recreational drug presentations to a large emergency department. Emerg Med J 2011; 28:387-389.
35. Wood DM, Hill SL, Thomas SH, Dargan PI. Using poisons information service data to assess the acute harms associated with novel psy-choactive substances. Drug Test Anal 2014; 6:850-860.
36. Meyer MR, Peters FT. Analytical toxicology of emerging drugs of abuse-an update. Ther Drug Monit 2012; 34:615-621.
37. United States Department of Health. Drug Abuse Warning Network (DAWN), 2010. 2013.
38. Wiegand TJ, Wax PM, Schwartz T, Finkelstein Y, Gorodetsky R, Brent J. The toxicology investigators consortium case registry-the 2011 experience. J Med Toxicol 2012; 8:360-377.